Mei'an Pharmaceutical signed an agreement with Legacy Health Care, a Swiss botanical drug research and development company

Publisher:Maxhealth  DATE:2017-8-31

In July 2017, Mei'an Pharmaceutical signed an agreement with Legacy & nbsp and Healthcare, a Swiss botanical drug research and development company, to jointly establish a joint venture with Mei'an Pharmaceutical as the controlling shareholder of the joint venture. Legacy granted the joint venture the right to distribute its hair loss treatment products in mainland China and Macao.